Turkish Adaptation, Validity, and Reliability Study of the Patient Experience With Treatment and Self-Management Scale in Stroke
1 other identifier
observational
170
1 country
1
Brief Summary
This study will include individuals aged 18-80 years who have been clinically diagnosed with stroke and have spent at least one month at home after discharge. Sociodemographic and clinical characteristics will be recorded. Functional status will be assessed using the Modified Rankin Scale, Brunnstrom Stages, and the Modified Barthel Index. Ambulation status will be documented with the Holden Scale. The scale will first be translated into Turkish and then back-translated into English by a bilingual expert whose native language is English. The Turkish version of the scale will be administered to patients. Two independent evaluators will apply the scale twice, one week apart. Validity will be examined by analyzing the relationship between the scale and the Stroke Impact Scale and the Treatment Burden Questionnaire
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2025
CompletedStudy Start
First participant enrolled
November 20, 2025
CompletedFirst Posted
Study publicly available on registry
November 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2026
CompletedNovember 28, 2025
November 1, 2025
5 months
November 19, 2025
November 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
PETS-Stroke scale
The primary measure, the PETS-Stroke scale, evaluates patients' experiences with treatment and self-management; its scoring system is based on subscale scores typically transformed to 0-100, with higher values reflecting greater perceived burden or difficulty in treatment and self-management.
Baseline
Secondary Outcomes (4)
The Modified Rankin Scale
Baseline
Modified Barthel Index
Baseline
Stroke Impact Scale
Baseline
Treatment Burden Questionnaire
Baseline
Interventions
no intervention
Eligibility Criteria
Clinical diagnosis of stroke (ischemic or hemorrhagic).
You may qualify if:
- Clinical diagnosis of stroke (ischemic or hemorrhagic).
- Having spent at least 1 month at home after hospital discharge (to capture post-acute home care/rehabilitation burden).
- Community-dwelling individuals aged 18-80 years.
- Adequate Turkish reading-writing and communication ability.
- Ability to provide informed consent.
- In cases of mild aphasia, ability to complete the questionnaire independently or with support.
You may not qualify if:
- History of subarachnoid hemorrhage.
- Inability to communicate effectively due to severe aphasia or severe cognitive impairment.
- Terminal illness (life expectancy \< 6 months).
- Inability to complete the questionnaire reliably due to a psychiatric disorder.
- Acute phase (those hospitalized or before discharge).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Week
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2025
First Posted
November 28, 2025
Study Start
November 20, 2025
Primary Completion
April 10, 2026
Study Completion
April 10, 2026
Last Updated
November 28, 2025
Record last verified: 2025-11